Journal article
Temporal bone carcinoma: Treatment patterns and survival
The Laryngoscope, Vol.130(1), pp.E11-E20
01/2020
DOI: 10.1002/lary.27877
PMCID: PMC6745298
PMID: 30874314
Abstract
Carcinomas of the temporal bone are rare, and appropriate treatment, staging, and survival data are limited. This study evaluates clinical characteristics and survival rates for patients with temporal bone carcinoma treated with resection at a single tertiary-care institution, with a focus on the outcomes of patients with locally advanced disease including skull base and/or dural invasion.
Retrospective chart review.
Demographic, tumor-specific, and survival data were collected for patients with primary carcinomas of the external auditory canal with involvement of the temporal bone from 2003 to 2015. All patients were staged according to the modified Pittsburgh system. Kaplan-Meier and logistic regression analysis were used to calculate factor-specific survival outcomes.
Sixty-seven patients met inclusion criteria; 85% were male. There were 43 squamous cell carcinomas (64%) and 24 basal cell carcinomas (BCCs) (36%). Tumor stage was 24 (36%) T2, 12 (18%) T3, and 31 (46%) T4 tumors; 53% had recurrent disease. Surgical management included 49 lateral temporal bone resections and 18 subtotal temporal bone resections. Kaplan-Meier analyses revealed more favorable 5-year survival rates associated with BCC histology (P = .01), lateral temporal bone resection compared to subtotal temporal bone resection (P < .01), lack of immunocompromise (P = .04), and absence of perineural/lymphovascular invasion (P = .01). Multivariate regression analysis did not yield statistically significant results.
Factors predictive of more favorable survival include lack of immunocompromise, BCC histology, absence of perineural/lymphovascular invasion, and disease extent amenable to lateral temporal bone resection. Dural invasion is not an absolute contraindication to surgery, with a subset of patients surviving >5 years.
3 Laryngoscope, 130:E11-E20, 2020.
Details
- Title: Subtitle
- Temporal bone carcinoma: Treatment patterns and survival
- Creators
- Kristen L Seligman - University of IowaDaniel Q Sun - University of IowaPatrick P Ten Eyck - University of IowaNathan M Schularick - Ear, Nose, and Throat SpecialtyCare of Minnesota, Minneapolis, Minnesota, U.S.A.Marlan R Hansen - University of Iowa
- Resource Type
- Journal article
- Publication Details
- The Laryngoscope, Vol.130(1), pp.E11-E20
- DOI
- 10.1002/lary.27877
- PMID
- 30874314
- PMCID
- PMC6745298
- NLM abbreviation
- Laryngoscope
- ISSN
- 0023-852X
- eISSN
- 1531-4995
- Grant note
- T32 DC000040 / NIDCD NIH HHS UL1 TR002537 / NCATS NIH HHS
- Language
- English
- Date published
- 01/2020
- Academic Unit
- Molecular Physiology and Biophysics; Biostatistics; Neurosurgery; Otolaryngology
- Record Identifier
- 9984297615302771
Metrics
24 Record Views